These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21740259)

  • 1. Designs and analyses of psychotropic and behavioral interventions for the treatment of problem behavior among people with intellectual and developmental disabilities.
    Courtemanche AB; Schroeder SR; Sheldon JB
    Am J Intellect Dev Disabil; 2011 Jul; 116(4):315-28. PubMed ID: 21740259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of behavioral interventions for the treatment of aggression in individuals with developmental disabilities.
    Brosnan J; Healy O
    Res Dev Disabil; 2011; 32(2):437-46. PubMed ID: 21239140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities.
    Schaal DW; Hackenberg T
    Am J Ment Retard; 1994 Sep; 99(2):123-40. PubMed ID: 7803030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview.
    Matson JL; Neal D
    Res Dev Disabil; 2009; 30(3):572-86. PubMed ID: 18845418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the effectiveness of individual intervention in the controlled multisensory environment (Snoezelen) for individuals with intellectual disability.
    Lotan M; Gold C
    J Intellect Dev Disabil; 2009 Sep; 34(3):207-15. PubMed ID: 19681001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature and treatment of compulsions, obsessions, and rituals in people with developmental disabilities.
    Matson JL; Dempsey T
    Res Dev Disabil; 2009; 30(3):603-11. PubMed ID: 19013755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of psychotropic medications in children with developmental disabilities.
    Calles JL
    Pediatr Clin North Am; 2008 Oct; 55(5):1227-40, ix. PubMed ID: 18929062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities.
    Hassiotis A; Robotham D; Canagasabey A; Romeo R; Langridge D; Blizard R; Murad S; King M
    Am J Psychiatry; 2009 Nov; 166(11):1278-85. PubMed ID: 19687128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying empirically supported treatments for phobic avoidance in individuals with intellectual disabilities.
    Jennett HK; Hagopian LP
    Behav Ther; 2008 Jun; 39(2):151-61. PubMed ID: 18502248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive challenging behaviour and intellectual disability.
    Benson BA; Brooks WT
    Curr Opin Psychiatry; 2008 Sep; 21(5):454-8. PubMed ID: 18650686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmet needs of people with developmental and intellectual disability.
    Bouras N
    Curr Opin Psychiatry; 2010 Sep; 23(5):405-6. PubMed ID: 20683178
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction to special section on evidence-based practices for persons with intellectual and developmental disabilities.
    Kaiser AP; McIntyre LL
    Am J Intellect Dev Disabil; 2010 Sep; 115(5):357-63. PubMed ID: 20687821
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychopharmacology and applied behavioral analysis: tandem treatment of severe problem behaviors in intellectual disability and a case series.
    Wachtel LE; Hagopian LP
    Isr J Psychiatry Relat Sci; 2006; 43(4):265-74. PubMed ID: 17338446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic medication use in people with developmental disabilities.
    Curtis JL
    Md Med J; 1997 Oct; 46(9):481-5. PubMed ID: 9327650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
    Rowles BM; Findling RL
    Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing problem behavior during care-giving in families of preschool-aged children with developmental disabilities.
    Plant KM; Sanders MR
    Res Dev Disabil; 2007; 28(4):362-85. PubMed ID: 16781115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulating the behavior-altering effect of the motivating operation: examination of the influence on challenging behavior during leisure activities.
    O'Reilly MF; Sigafoos J; Lancioni G; Rispoli M; Lang R; Chan J; Machalicek W; Langthorne P
    Res Dev Disabil; 2008; 29(4):333-40. PubMed ID: 17629672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.